VetSRev
Database of veterinary systematic reviews
Database of veterinary systematic reviews
Parasit Vectors (2019) 12: 99
DOI: 10.1186/s13071-019-3340-z
BACKGROUND: Sarcoptic mange, caused by the Sarcoptes scabiei mite, is an infectious disease of wildlife, domestic animals and humans with international importance. Whilst a variety of treatment and control methods have been investigated in wildlife, the literature is fragmented and lacking consensus. The primary objectives of this review were to synthesise the diverse literature published on the treatment of sarcoptic mange in wildlife from around the world, and to identify the qualities of successful treatment strategies in both captive and free-roaming wildlife. METHODS: A systematic search of the electronic databases CAB Direct, PubMed, Scopus, Web of Science, EMBASE and Discovery was undertaken. Data pertaining to study design, country, year, species, study size, mange severity, treatment protocol and outcomes were extracted from eligible studies and placed in a table. Following data extraction, a decision tree was used to identify studies suitable for further analysis based on the effectiveness of their treatment protocol, whether they were conducted on captive or non-captive wildlife, and the quality of their post-treatment monitoring period. RESULTS: Twenty-eight studies met our initial inclusion criteria for data collection. Of these studies, 15 were selected for further analysis following application of the decision tree. This comprised of 9 studies on captive wildlife, 5 studies on free-living wildlife and 1 study involving both captive and free-living wildlife. Ivermectin delivered multiple times via subcutaneous injection at a dose between 200-400 µg/kg was found to be the most common and successfully used treatment, although long-term data on post-release survival and re-infection rates was elusive. CONCLUSIONS: To our knowledge, this review is the first to demonstrate that multiple therapeutic protocols exist for the treatment of sarcoptic mange in wildlife. However, several contemporary treatment options are yet to be formally reported in wildlife, such as the use of isoxazoline chemicals as a one-off treatment. There is also a strong indication for more randomised controlled trials, as well as improved methods of post-treatment monitoring. Advancing this field of knowledge is expected to aid veterinarians, wildlife workers and policy makers with the design and implementation of effective treatment and management strategies for the conservation of wildlife affected by sarcoptic mange.
Rowe, M. L., Whiteley, P. L., & Carver, S. (2019). The treatment of sarcoptic mange in wildlife: a systematic review. Parasit Vectors, 12(1), 99. https://doi.org/10.1186/s13071-019-3340-z Animals, Humans, Treatment Outcome, Conservation of Natural Resources, Treatment, Animals, Wild, Wildlife, Injections, Subcutaneous, Control, Animals, Domestic, Ivermectin/*administration & dosage, Sarcoptic mange, Insecticides/*administration & dosage, Sarcoptes scabiei, Sarcoptes scabiei/*drug effects, Scabies/*drug therapy/parasitology